|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-000
|
|
IUPAC
|
|
N-[(4-methyl-5,6,7,8-tetrahydroquinazolin-2-yl)methyl]-6-(piperidin-4-yl)pyrimidin-4-amine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-001
|
|
IUPAC
|
|
2-{4-[(2,6-dimethoxypyridin-3-yl)carbonyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl}-4-(1H-pyrazol-1-yl)butan-2-ol
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-002
|
|
IUPAC
|
|
2-fluoro-N-{[7-(4-methanesulfonylphenyl)-2,3-dihydro-1-benzofuran-2-yl]methyl}benzamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-003
|
|
IUPAC
|
|
(1S,4S)-2-(2-methoxy-5-methylphenyl)-5-(thiophen-3-ylmethyl)-2,5-diazabicyclo[2.2.1]heptan-3-one
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-004
|
|
IUPAC
|
|
1-(2-{4-[(3-ethoxy-2-hydroxyphenyl)methyl]piperazin-1-yl}ethyl)-N-(propan-2-yl)-1H-1,2,3-triazole-4-carboxamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-005
|
|
IUPAC
|
|
N-(4-methoxyphenyl)-1-{[4-(trifluoromethyl)phenyl]carbonyl}piperidin-3-amine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-006
|
|
IUPAC
|
|
4-(5-{[(2-chlorophenyl)carbamoyl]amino}-1H-pyrazol-1-yl)-N-cyclohexylpiperidine-1-carboxamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-007
|
|
IUPAC
|
|
4-(2-methoxyethyl)-1-(2-phenylpropyl)-1,4-diazepan-5-one
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-008
|
|
IUPAC
|
|
2-(4-methoxyphenoxymethyl)-6-(1-methylpiperidin-3-yl)-3,4-dihydropyrimidin-4-one
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-009
|
|
IUPAC
|
|
N-(prop-2-en-1-yl)-N-(prop-2-yn-1-yl)-4-{[1-(pyridin-2-ylmethyl)piperidin-4-yl]oxy}benzamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-010
|
|
IUPAC
|
|
ethyl 4-{1-[(4-fluoro-3-methoxyphenyl)methyl]piperidin-3-yl}piperazine-1-carboxylate
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-011
|
|
IUPAC
|
|
2-(4-methoxy-3-methylphenyl)-5-(quinoxalin-5-ylmethyl)-2,3,4,5-tetrahydro-1,5-benzothiazepine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-012
|
|
IUPAC
|
|
2,4-dimethyl-N-[4-(4-{[3-(4-methyl-1,3-thiazol-5-yl)propyl]amino}piperidin-1-yl)phenyl]benzamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-013
|
|
IUPAC
|
|
6-(aminomethyl)-2-(4-{[2-(2-methylphenyl)pyrrolidin-1-yl]methyl}phenyl)-3,4-dihydropyrimidin-4-one
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-014
|
|
IUPAC
|
|
N-({4-benzyl-5-[(oxolan-2-ylmethyl)sulfanyl]-4H-1,2,4-triazol-3-yl}methyl)-2H-1,3-benzodioxole-5-carboxamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-015
|
|
IUPAC
|
|
N-(2-{imidazo[2,1-b][1,3]thiazol-6-yl}ethyl)-6-methylpyridazin-3-amine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-016
|
|
IUPAC
|
|
N-(5-chloro-2-methoxyphenyl)-3-{1-[(1-ethyl-1H-pyrazol-4-yl)methyl]piperidin-3-yl}propanamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-017
|
|
IUPAC
|
|
1-(2-{3-[2-(3-fluorophenyl)ethyl]piperidin-1-yl}-2-oxoethyl)piperidin-2-one
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-018
|
|
IUPAC
|
|
1-{[2-(2,3-difluorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-4-[(4-methoxyphenyl)carbonyl]piperazine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-019
|
|
IUPAC
|
|
4-[(3-chlorophenyl)methyl]-9-methoxy-7-(6-methoxypyridin-2-yl)-2,3,4,5-tetrahydro-1,4-benzoxazepine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-020
|
|
IUPAC
|
|
N-(1-{1-[(3-ethoxyphenyl)methyl]piperidin-4-yl}-1H-pyrazol-5-yl)-4-phenylbutanamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-021
|
|
IUPAC
|
|
2-methyl-4-{4-[({1-[5-methyl-1-(naphthalen-1-yl)-1H-pyrazol-4-yl]ethyl}amino)methyl]phenyl}but-3-yn-2-ol
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-022
|
|
IUPAC
|
|
{1-[(1-ethyl-1H-imidazol-2-yl)methyl]-4-(2-phenoxyethyl)piperidin-4-yl}methanol
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-023
|
|
IUPAC
|
|
(2S)-1-{[2-(2,3-difluorophenoxymethyl)-1,3-oxazol-4-yl]carbonyl}-4-methyl-2-(propan-2-yl)piperazine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-024
|
|
IUPAC
|
|
4-[2-(oxolan-2-yl)-3H-imidazo[4,5-b]pyridin-3-yl]-1-{[4-(1H-pyrazol-1-yl)phenyl]carbonyl}piperidine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-025
|
|
IUPAC
|
|
(3S,4S)-1-(2,1,3-benzoxadiazol-4-ylmethyl)-4-[4-(pyridin-2-yl)piperazin-1-yl]pyrrolidin-3-ol
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-026
|
|
IUPAC
|
|
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-{1-[2-(thiophen-3-yl)acetyl]piperidin-4-yl}propanamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-027
|
|
IUPAC
|
|
N-cyclopentyl-1-{1-[(2E)-3-[4-(dimethylamino)phenyl]prop-2-en-1-yl]piperidin-3-yl}-1H-1,2,3-triazole-4-carboxamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-028
|
|
IUPAC
|
|
4-(1-{[3-(2-phenylpropyl)-1,2-oxazol-5-yl]carbonyl}piperidin-4-yl)pyridine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-029
|
|
IUPAC
|
|
2-[(1-cyclopentylpiperidin-4-yl)oxy]-5-methoxy-N-[3-(methylsulfanyl)propyl]benzamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-030
|
|
IUPAC
|
|
1-(3,4-dimethylphenyl)-N-(isoquinolin-5-ylmethyl)-4,5,6,7-tetrahydro-1H-indazol-4-amine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-031
|
|
IUPAC
|
|
(4aR,8aS)-6-{[5-(2-chlorophenyl)furan-2-yl]methyl}-1-[2-(3-methoxyphenyl)ethyl]-decahydro-1,6-naphthyridin-2-one
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-032
|
|
IUPAC
|
|
7-(cyclohexylmethyl)-2-methyl-2,7-diazaspiro[4.5]decan-6-one
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-033
|
|
IUPAC
|
|
4-{2-[(3-methoxyphenyl)carbamoyl]ethyl}-N-[2-(methylsulfanyl)phenyl]piperidine-1-carboxamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-034
|
|
IUPAC
|
|
N,N-dimethyl-5-({methyl[(1-{2-[3-(trifluoromethyl)phenyl]ethyl}piperidin-3-yl)methyl]amino}methyl)-1,3-thiazol-2-amine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-035
|
|
IUPAC
|
|
N-({1-[(2-methylphenyl)methyl]piperidin-4-yl}methyl)-2-(pyridin-3-yl)-N-(pyridin-3-ylmethyl)acetamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-036
|
|
IUPAC
|
|
N-[2-(3-methoxyphenyl)ethyl]-5-methyl-6-[(pyrrolidin-1-yl)carbonyl]thieno[2,3-d]pyrimidin-4-amine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-037
|
|
IUPAC
|
|
4-{[3-(3-fluorophenyl)-1-(3-methylphenyl)-1H-pyrazol-4-yl]methyl}morpholine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-038
|
|
IUPAC
|
|
methyl (2S,4S)-1-[1-(2-phenylethyl)piperidin-4-yl]-4-{[2-(1H-pyrazol-1-yl)benzene]amido}pyrrolidine-2-carboxylate
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-005-122-039
|
|
IUPAC
|
|
1-[(2-fluorophenyl)methyl]-N-[3-(2-oxopyrrolidin-1-yl)propyl]-1H-1,2,3-triazole-4-carboxamide
|
|
|
|